Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine

Antiviral Research

Volumn 116, Issue , 2015, Pages 51-54

  Alidjinou, Enagnon Kazali ^a   Sané, Famara ^a   Bertin, Antoine ^a   Caloone, Delphine ^a   Hober, Didier ^a  

^a University Lille   (France)

Author keywords

Antiviral activity; Coxsackievirus B4; Fluoxetine; Persistent infection

Indexed keywords

FLUOXETINE; G PROTEIN COUPLED RECEPTOR; GLUTAMINE; NEUROTRANSMITTER RECEPTOR; RNA; UNCLASSIFIED DRUG; VIRAL PROTEIN 2C; VIRUS PROTEIN; ANTIVIRUS AGENT; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; COXSACKIE VIRUS B4; COXSACKIE VIRUS INFECTION; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; DRUG MECHANISM; HEP 2 CELL LINE; HUMAN; HUMAN CELL; INFECTION; PANCREAS CELL; PANCREATITIS; PERSISTENT INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL INOCULATION; VIRUS ENTRY; VIRUS PARTICLE; VIRUS REPLICATION; DRUG EFFECTS; ENTEROVIRUS B; GENETICS; PANCREAS DUCT; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIROLOGY;

COXSACKIEVIRUS;

ANTIVIRAL AGENTS; CELL LINE, TUMOR; ENTEROVIRUS B, HUMAN; FLUOXETINE; HUMANS; PANCREATIC DUCTS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRUS REPLICATION;

EID: 84922724752     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.01.010     Document Type: Article

References (16)

1. E.K. Alidjinou, F. Sané, I. Engelmann, and D. Hober Serum-dependent enhancement of coxsackievirus B4-induced production of IFNα, IL-6 and TNFα by peripheral blood mononuclear cells J. Mol. Biol. 425 2013 5020 5031
2. C.M. Beasley, D.N. Masica, and J.H. Potvin Fluoxetine: a review of receptor and functional effects and their clinical implications Psychopharmacology 107 1992 1 10
3. A.M. De Palma, I. Vliegen, E. De Clercq, and J. Neyts Selective inhibitors of picornavirus replication Med. Res. Rev. 28 2008 823 884
4. D. Hober, and E.K. Alidjinou Enteroviral pathogenesis of type 1 diabetes: queries and answers Curr. Opin. Infect. Dis. 26 2013 263 269
5. D. Hober, and P. Sauter Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host Nat. Rev. Endocrinol. 6 2010 279 289
6. H. Jaïdane, and D. Hober Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes Diabetes Metab. 34 2008 537 548
7. H. Jaïdane, P. Sauter, F. Sane, A. Goffard, J. Gharbi, and D. Hober Enteroviruses and type 1 diabetes: towards a better understanding of the relationship Rev. Med. Virol. 20 2010 265 280
8. N.J. Knowles, T. Hovi, T. Hyypiä, A.M.Q. King, A.M. Lindberg, M.A. Pallansch, A.C. Palmenberg, P. Simmonds, T. Skern, G. Stanway, T. Yamashita, and R. Zell Picornaviridae A.M.Q. King, M.J. Adams, E.B. Carstens, E.J. Lefkowitz, Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses 2012 Elsevier San Diego 855 880
9. E.C. Lauterbach Psychotropic drug effects on gene transcriptomics relevant to Parkinson's disease Prog. Neuropsychopharmacol. Biol. Psychiatry 38 2012 107 115
10. M.J. Millan MicroRNA in the regulation and expression of serotonergic transmission in the brain and other tissues Curr. Opin. Pharmacol. 11 2011 11 22
11. J.R. Romero Pediatric group B coxsackievirus infections Curr. Top. Microbiol. Immunol. 323 2008 223 239
12. F. Sane, D. Caloone, V. Gmyr, I. Engelmann, S. Belaich, J. Kerr-Conte, F. Pattou, R. Desailloud, and D. Hober Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates Cell. Mol. Life Sci. CMLS 70 2013 4169 4180
13. C. Tapparel, F. Siegrist, T.J. Petty, and L. Kaiser Picornavirus and enterovirus diversity with associated human diseases Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis. 14 2013 282 293
14. H.J. Thibaut, P. Leyssen, G. Puerstinger, A. Muigg, J. Neyts, and A.M. De Palma Towards the design of combination therapy for the treatment of enterovirus infections Antiviral Res. 90 2011 213 217
15. R. Ulferts, L. van der Linden, H.J. Thibaut, K.H.W. Lanke, P. Leyssen, B. Coutard, A.M. De Palma, B. Canard, J. Neyts, and F.J.M. van Kuppeveld Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C Antimicrob. Agents Chemother. 57 2013 1952 1956
16. J. Zuo, K.K. Quinn, S. Kye, P. Cooper, R. Damoiseaux, and P. Krogstad Fluoxetine is a potent inhibitor of coxsackievirus replication Antimicrob. Agents Chemother. 56 2012 4838 4844